Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Salestools Logo

Salestools

The #1 AI Agent for Sales teams and Go To Market teams. Sell more, faster, with less effort.

Product

  • AI Sales Agents
  • Intent Data
  • Technology Data
  • Visitor Tracking
  • Co-Pilot
  • Social Selling

Solutions

  • Customer Service
  • E-commerce
  • SaaS
  • Enterprise
  • Small Business

Resources

  • The Report
  • Documentation
  • API Reference
  • Help Center
  • Blog
  • Case Studies
  • Webinars

Company

  • About
  • Careers
  • Press
  • Contact
  • Partners

Our locations

  • New York, HQ
  • Bucharest, AI Research Lab
  • Zug, Switzerland

Β© 2026 Salestools. All rights reserved.

Data Terms & SecurityPrivacy PolicyTerms of ServiceAcceptable Use
All systems operational
Salestools LogoSalestools
Salestools AI Agents
Solutions
Resources
Company
Pricing
Back to Reports
Fundraising

The Hershey Company

The Hershey Company Raises $40B in Public

19 East Chocolate Avenue, Hershey, PA 17033January 1, 20242 min read
Employees
21800+

The Hershey Company Raises $40B in Public


The Hershey Company has successfully raised $40B in a Public at a $42B valuation led by Public.


Company Overview


The Hershey Company is a Food & Beverage company headquartered in 19 East Chocolate Avenue, Hershey, PA 17033, founded in 1894 with 21800+ employees.


Chocolate manufacturer


Fundraising Details


  • Amount Raised: $40B
  • Round Type: Public
  • Valuation: $42B
  • Date: 2024-01-01
  • Investors: Public

About The Hershey Company


Chocolate manufacturer The company is positioned in the Food & Beverage sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 19 East Chocolate Avenue, Hershey, PA 17033
  • Founded: 1894
  • Team Size: 21800+
  • Industry: Food & Beverage

What This Means


This funding round demonstrates strong investor confidence in The Hershey Company's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Food & Beverage sector continues to attract significant investment as companies innovate to meet evolving market demands. The Hershey Company's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $42B valuation marks an important milestone for The Hershey Company, positioning the company among notable players in the Food & Beverage industry.


Looking Ahead


With this new capital, The Hershey Company is well-positioned to execute on its growth strategy and continue building innovative solutions in the Food & Beverage space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about The Hershey Company, visit their headquarters at 19 East Chocolate Avenue, Hershey, PA 17033.

Company Info

Headquarters
19 East Chocolate Avenue, Hershey, PA 17033
Founded
1894
Team Size
21800+

Topics

Fundraising(2912)Public(771)Food & BeverageThe Hershey Company

Share

Related Reports

Fundraising
Tebra

Tebra Raises $250M Growth Financing | Healthcare Practice Management Platform

Healthcare practice management platform Tebra secures $250 million in growth financing led by Hildred Capital for AI-driven automation.

SalesTools Research
SalesTools Research
Jan 12, 2026
0 min readβ€’$250M
Fundraising
Harmattan AI

Harmattan AI Raises $200M Series B | Defense Tech Unicorn at $1.4B Valuation

French defense tech company Harmattan AI secures $200 million Series B led by Dassault Aviation, reaching unicorn status.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
SalesTools Research
Jan 11, 2026
0 min readβ€’$200M

Turn your sales ideas into reality today

Start your 14-day Pro trial today. No credit card required.

Start building for free